SHARE-BASED COMPENSATION (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary of the components and classification of share-based compensation expense

The following table summarizes the components and classification of the Company’s share-based compensation expenses related to stock options and RSUs for the three months ended March 31, 2023 and 2022:

	Three Months Ended March 31,
(in millions)	2023		2022
Stock options	$	6	$	4
RSUs	35		28
	$	41	$	32
Research and development expenses	$	3	$	3
Selling, general and administrative expenses	38		29
	$	41	$	32

Summary of share-based awards

Share-based awards granted for the three months ended March 31, 2023 and 2022 consist of:

	2023		2022
Bausch Health Share-Based Awards
Stock options
Granted	999,000		2,545,000
Weighted-average exercise price	$	9.25	$	24.08
Weighted-average grant date fair value	$	4.87	$	6.63
Time-based RSUs
Granted	4,133,000		1,662,000
Weighted-average grant date fair value	$	9.18	$	24.21
Adjusted Operating Cash Flow performance-based RSUs
Granted	647,000		—
Weighted-average grant date fair value	$	10.57	$	—
Bausch+ Lomb Share-Based Awards
Stock options
Granted	2,679,000		—
Weighted-average exercise price	$	18.27	$	—
Weighted-average grant date fair value	$	5.52	$	—
RSUs
Granted	2,358,000		—
Weighted-average grant date fair value	$	18.04	$	—
TSR performance-based RSUs
Granted	1,175,000		—
Weighted-average grant date fair value	$	27.65	$	—
Organic Revenue Growth performance-based RSUs
Granted	142,000		—
Weighted-average grant date fair value	$	17.96	$	—